Company intelligence / Profile preview

First Eagle

New York, New York, United States

Ownership: Private
Employees: ~500
Development stage: Other

Overview

First Eagle Investments is an independent, privately owned investment management firm headquartered in New York City. While not a biotechnology or pharmaceutical company itself, the firm is a significant institutional investor in the healthcare and life sciences sectors through its various equity strategies and specialized funds. The firm manages assets for institutional and individual clients globally, employing a fundamental, value-oriented investment philosophy that often includes long-term positions in major pharmaceutical, medical device, and healthcare services companies.

Industry: Investors

Beyond the preview

Go deeper on First Eagle.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on First Eagle.

Explore the full profile